
Ziccum Investor Relations Material
Latest events

Status Update
Ziccum

Status Update
27 Nov, 2024

Q3 2024
1 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ziccum
Access all reports
Ziccum is a Sweden-based pharmaceutical company specializing in the development of vaccines. It focuses on creating new thermostable versions of vaccines and biologics through its patented drying technology, LaminarPace. This unique method relies on mass transfer instead of heat transfer, enabling the production of particle-engineered, thermostable dry powder biopharmaceuticals. These powders can be easily handled and transported, and they are suitable for novel administration routes, eliminating the need for cold chain logistics. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ZICC
Country
🇸🇪 Sweden